Valtoco and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Valtoco (diazepam), especially for people who are female, 2-9 old, also take Epinephrine, and have Failure to thrive.

The phase IV clinical study analyzes which people have Weakness when taking Valtoco. It is created by eHealthMe based on reports of 400 people who have side effects when taking Valtoco from the FDA, and is updated regularly.

What is Valtoco?

Valtoco has active ingredients of diazepam. eHealthMe is studying from 400 Valtoco users. Check the latest studies of Valtoco.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,589 conditions by eHealthMe. Check the latest studies of Weakness.

On Apr, 18, 2026

400 people reported to have side effects when taking Valtoco.
Among them, 9 people (2.25%) have Weakness.

Among these 9 people:

What is the gender of people who have Weakness when taking Valtoco? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Weakness when taking Valtoco? *

What are other drugs people take besides Valtoco? *

Clobazam: 3 people, 33.33%
Epinephrine: 3 people, 33.33%
Heparin: 2 people, 22.22%
Diastat Acudial: 2 people, 22.22%
Keppra: 2 people, 22.22%
Ibuprofen: 2 people, 22.22%
Xopenex Hfa: 2 people, 22.22%
Fluticasone Propionate: 2 people, 22.22%
Epidiolex: 2 people, 22.22%
Diastat: 2 people, 22.22%

What are other side effects people have besides Weakness? *

Weight Decreased: 5 people, 55.56%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 5 people, 55.56%
The Flu (the flu is caused by an influenza virus): 4 people, 44.44%
Diarrhea: 4 people, 44.44%
Dehydration (dryness resulting from the removal of water): 4 people, 44.44%
Cough: 4 people, 44.44%
Fall: 4 people, 44.44%
Fatigue (feeling of tiredness): 4 people, 44.44%
Nausea And Vomiting: 3 people, 33.33%
Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 33.33%

What are the existing conditions these people have? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 22.22%
Mitochondrial Myopathy (the muscle fibres do not function due to damage of mitochondria): 2 people, 22.22%
Immunodeficiency Common Variable: 2 people, 22.22%
Failure To Thrive (inadequate weight gain and physical growth in children): 2 people, 22.22%
Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 1 person, 11.11%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 11.11%
Cardiac Disorder: 1 person, 11.11%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Valtoco and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Valtoco:

Valtoco (400 reports)

Weakness treatments and more:

Weakness (586,873 reports)

Browse all side effects of Valtoco:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,639 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,589 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diazepam (the active ingredients of Valtoco) and Valtoco (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.